|
|
Volumn 310, Issue 16, 2013, Pages 1661-1663
|
|
Report reveals scope of US antibiotic resistance threat
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
CARBAPENEM;
CEPHALOSPORIN;
CLINDAMYCIN;
ERYTHROMYCIN;
METICILLIN;
PNEUMOCOCCUS VACCINE;
VANCOMYCIN;
ACINETOBACTER;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BACTERIAL STRAIN;
CAMPYLOBACTER;
CLOSTRIDIUM DIFFICILE;
CLOSTRIDIUM DIFFICILE INFECTION;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG RESISTANT TUBERCULOSIS;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
ENTEROBACTERIACEAE;
ENTEROCOCCUS;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HUMAN;
INFECTION PREVENTION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MORBIDITY;
NEISSERIA GONORRHOEAE;
NONHUMAN;
PNEUMOCOCCAL INFECTION;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT SURVEY;
STREPTOCOCCUS;
UNITED STATES;
VACCINATION;
VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;
|
|
EID: 84886260592
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2013.280695 Document Type: Short Survey |
|
Times cited : (96)
|
|
References (0)
|
